Collins, K. C., Clark, A. B., Pomeroy, V. M. and Kennedy, N. C., 2024. The test-retest reliability of non-navigated transcranial magnetic stimulation (TMS) measures of corticospinal pathway excitability early after stroke. Disability and Rehabilitation. (In Press)
Full text available as:
|
PDF (OPEN ACCESS ARTICLE)
The test-retest reliability of non-navigated transcranial magnetic stimulation TMS measures of corticospinal pathway excitability early after stroke.pdf - Published Version Available under License Creative Commons Attribution Non-commercial No Derivatives. 1MB | |
Copyright to original material in this document is with the original owner(s). Access to this content through BURO is granted on condition that you use it only for research, scholarly or other non-commercial purposes. If you wish to use it for any other purposes, you must contact BU via BURO@bournemouth.ac.uk. Any third party copyright material in this document remains the property of its respective owner(s). BU grants no licence for further use of that third party material. |
DOI: 10.1080/09638288.2024.2337107
Abstract
Purpose: Motor evoked potential (MEP) characteristics are potential biomarkers of whether rehabilitation interventions drive motor recovery after stroke. The test-retest reliability of Transcranial Magnetic Stimulation (TMS) measurements in sub-acute stroke remains unclear. This study aims to determine the test-retest reliability of upper limb MEP measures elicited by non-neuronavigated transcranial magnetic stimulation in sub-acute-stroke. Methods: In two identical data collection sessions, 1–3 days apart, TMS measures assessed: motor threshold (MT), amplitude, latency (MEP-L), silent period (SP), recruitment curve slope in the biceps brachii (BB), extensor carpi radialis (ECR), and abductor pollicis brevis (APB) muscles of paretic and non-paretic upper limbs. Test-retest reliability was calculated using the intra-class correlation coefficient (ICC) and 95% confidence intervals (CI). Acceptable reliability was set at a lower 95% CI of 0.70 or above. The limits of agreement (LOA) and smallest detectable change (SDC) were calculated. Results: 30 participants with sub-acute stroke were included (av 36 days post stroke) reliability was variable between poor to good for the different MEP characteristics. The SDC values differed across muscles and MEP characteristics in both paretic and less paretic limbs. Conclusions: The present findings indicate there is limited evidence for acceptable test-retest reliability of non-navigated TMS outcomes when using the appropriate 95% CI for ICC, SDC and LOA values. Clinical Trial Registration: Current Controlled Trials: ISCRT 19090862, http://www.controlled-trials.com.
Item Type: | Article |
---|---|
ISSN: | 0963-8288 |
Uncontrolled Keywords: | test-retest reliability; transcranial magnetic stimulation (tMs); smallest detectable change; stroke; upper limb |
Group: | Faculty of Health & Social Sciences |
ID Code: | 39753 |
Deposited By: | Symplectic RT2 |
Deposited On: | 29 Apr 2024 13:59 |
Last Modified: | 29 Apr 2024 13:59 |
Downloads
Downloads per month over past year
Repository Staff Only - |